Cancer Test Provider Raises $238M In IPO As Shares Soar
Cancer-testing startup Guardant Health raised $238 million in an initial public offering that priced well above range and saw shares surge in debut trading Thursday, while biotechnology firm Kodiak Sciences raised...To view the full article, register now.
Already a subscriber? Click here to view full article